| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $127.1M | +40.8% |
| Cost of Revenue | $30.2M | +69.7% |
| R&D Expense | $31.1M | +26.4% |
| SG&A Expense | $39.1M | +89.3% |
| Operating Income | -$29.7M | -408.5% |
| Pre-tax Income | -$16.4M | -60.2% |
| Income Tax | $2.0M | +63.1% |
| Net Income | -$18.4M | -60.5% |
| EPS (Basic) | -$0.14 | +95.8% |
| EPS (Diluted) | -$0.14 | +95.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.5M | -76.0% |
| Accounts Receivable | $43.7M | +23.2% |
| Current Assets | $93.8M | -51.9% |
| Total Assets | $259.6M | +26.3% |
| Current Liabilities | $21.2M | -3.0% |
| Long-term Debt | $20.0M | — |
| Total Liabilities | $53.7M | +21.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.6M | -377.5% |
| Capital Expenditures | $488K | -11.1% |
| Investing Cash Flow | -$119.4M | -3139.1% |
| Financing Cash Flow | $11.8M | -92.0% |
| Free Cash Flow | -$12.0M | -305.7% |
| Stockholders' Equity |
| $205.9M |
| +27.7% |